|
KLHL5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62503344114384E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62503344114384E-12 |
| Normal-vs-Stage2 |
3.84430000055502E-07 |
| Normal-vs-Stage3 |
2.50370002508049E-09 |
| Normal-vs-Stage4 |
3.994400E-02 |
| Stage1-vs-Stage2 |
2.280600E-01 |
| Stage1-vs-Stage3 |
3.169000E-01 |
| Stage1-vs-Stage4 |
3.172600E-01 |
| Stage2-vs-Stage3 |
7.557000E-01 |
| Stage2-vs-Stage4 |
6.048800E-01 |
| Stage3-vs-Stage4 |
5.442800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
3.36959999902575E-08 |
| Normal-vs-Asian |
1.139770E-03 |
| Caucasian-vs-AfricanAmerican |
1.298020E-02 |
| Caucasian-vs-Asian |
4.400400E-01 |
| AfricanAmerican-vs-Asian |
9.096600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.51459999986336E-07 |
| Male-vs-Female |
1.336120E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.5282999945081E-08 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
3.68920005655582E-10 |
| Normal-vs-Extreme_Obese |
4.72990000499607E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.088210E-02 |
| Normal_Weight-vs-Obese |
7.524600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.533430E-01 |
| Extreme_Weight-vs-Obese |
2.415800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.364600E-01 |
| Obese-vs-Extreme_Obese |
3.171600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.17960000000028E-05 |
| Normal-vs-Age(41-60Yrs) |
8.70414851306123E-14 |
| Normal-vs-Age(61-80Yrs) |
2.72004641033163E-14 |
| Normal-vs-Age(81-100Yrs) |
2.83490000363429E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.590200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.772000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.398500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.165400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.180400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.642000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
4.71899996856706E-09 |
| Normal-VS-KIRP CIMP |
5.958400E-02 |
| Normal-VS-Unclassified PRCC |
3.39179999997441E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.457700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.011800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.484600E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.440400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.092000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.976180E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.00470800754738E-14 |
| Normal-vs-N1 |
1.825380E-04 |
| Normal-vs-N2 |
4.482800E-01 |
| N0-vs-N1 |
5.863000E-03 |
| N0-vs-N2 |
3.611400E-01 |
| N1-vs-N2 |
6.892200E-01 |
|
|
